All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
EquityEquity IPOs

Brain presses on with €35m bio IPO despite rough markets

Brain 230x150

Biotechnology Research And Information Network, the German biotech business, has set a price range of €9 to €12 a share for its Frankfurt listing, implying a market cap of €148m to €197m.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree